Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training

European Journal of Endocrinology

Volumn 158, Issue 2, 2008, Pages 163-172

  Praet, Stephan F E ^a   Jonkers, R A M ^a   Schep, G ^b   Stehouwer, C D A ^c   Kuipers, H ^a   Keizer, H A ^d   van Loon, L J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLIMEPIRIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN GLARGINE; ISOPHANE INSULIN; METFORMIN; SULFONYLUREA; TUMOR NECROSIS FACTOR ALPHA; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BEDTIME DOSAGE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN SENSITIVITY; INTERVENTION STUDY; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; MUSCLE STRENGTH; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; FEASIBILITY STUDY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSICAL EDUCATION; SKELETAL MUSCLE; TIME; TREATMENT OUTCOME; WORK;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; EXERCISE; FEASIBILITY STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PHYSICAL EDUCATION AND TRAINING; TIME FACTORS; TREATMENT OUTCOME; WORK;

EID: 38949168972     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0169     Document Type: Article

References (82)

1. Balducci S, Leonetti F, Di Mario U & Fallucca F. Is a long-term aerobic plus resistance training program feasible for and effective on metabolic profiles in type 2 diabetic patients? Diabetes Care 2004 27 841-842.
2. Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN & Galbo H. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 1995 44 1010-1020.
3. Snowling NJ & Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care 2006 29 2518-2527.
4. Santeusanio F, Di Loreto C, Lucidi P, Murdolo G, De Cicco A, Parlanti N, Piccioni F & De Feo P. Diabetes and exercise. Journal of Endocrinological Investigation 2003 26 937-940.
5. Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2004 65 S23-S27.
6. Reenders K, De Nobel E, Van Den Hoogen HJ, Rutten GE & Van Weel C. Diabetes and its long-term complications in general practice: a survey in a well-defined population. Family Practice 1993 10 169-172.
7. Franklin GM, Kahn LB, Baxter J, Marshall JA & Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. American Journal of Epidemiology 1990 131 633-643.
8. Franklin GM, Shetterly SM, Cohen JA, Baxter J & Hamman RF. Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1994 17 1172-1177.
9. Andersen H, Nielsen S, Mogensen CE & Jakobsen J. Muscle strength in type 2 diabetes. Diabetes 2004 53 1543-1548.
10. Volpato S, Blaum C, Resnick H, Ferrucci L, Fried LP & Guralnik JM. Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women's Health and Aging Study. Diabetes Care 2002 25 678-683.
11. Sayer AA, Dennison EM, Syddall HE, Gilbody HJ, Phillips DI & Cooper C. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care 2005 28 2541-2542.
12. De Rekeneire N, Resnick HE, Schwartz AV, Shorr RI, Kuller LH, Simonsick EM, Vellas B & Harris TB. Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the health, aging, and body composition study. Diabetes Care 2003 26 3257-3263.
13. Wei M, Gibbons LW, Kampert JB, Nichaman MZ & Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Annals of Internal Medicine 2000 132 605-611.
14. Howorka K, Pumprla J, Haber P, Koller-Strametz J, Mondrzyk J & Schabmann A. Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovascular Research 1997 34 206-214.
15. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C & White RD. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 2006 29 1433-1438.
16. Meyer K, Samek L, Schwaibold M, Westbrook S, Hajric R, Beneke R, Lehmann M & Roskamm H. Interval training in patients with severe chronic heart failure: analysis and recommendations for exercise procedures. Medicine and Science in Sports and Exercise 1997 29 306-312.
17. Meyer K, Stengele E, Westbrook S, Beneke R, Schwaibold M, Gornandt L, Lehmann M & Roskamm H. Influence of different exercise protocols on functional capacity and symptoms in patients with chronic heart failure. Medicine and Science in Sports and Exercise 1996 28 1081-1086.
18. Detournay B, Raccah D, Cadilbac M & Eschwege E. Epidemiology and costs of diabetes treated with insulin in France. Diabetes and Metabolism 2005 31 3-18.
19. Defronzo RA, Ferrannini E, Sato Y, Felig P & Wahren J. Synergistic interaction between exercise and insulin on peripheral glucose uptake. Journal of Clinical Investigation 1981 68 1468-1474.
20. Marin P, Andersson B, Krotkiewski M & Bjorntorp P. Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 1994 17 382-386.
21. Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, Israel RG & Dohm GL. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. American Journal of Physiology 1995 268 E453-E457.
22. Tanner CJ, Barakat HA, Dohm GL, Pories WJ, Macdonald KG, Cunningham PR, Swanson MS & Houmard JA. Muscle fiber type is associated with obesity and weight loss. American Journal of Physiology. Endocrinology and Metabolism 2002 282 E1191-E1196.
23. Venojarvi M, Puhke R, Hamalainen H, Marniemi J, Rastas M, Rusko H, Nuutila P, Hanninen O & Aunola S. Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exercise and dietary intervention. Diabetes, Obesity and Metabolism 2005 7 745-754.
24. Daugaard JR & Richter EA. Relationship between muscle fibre composition, glucose transporter protein 4 and exercise training: possible consequences in non-insulin-dependent diabetes mellitus. Acta Physiologica Scandinavica 2001 171 267-276.
25. He J & Kelley DE. Muscle glycogen content in type 2 diabetes mellitus. American Journal of Physiology. Endocrinology and Metabolism 2004 287 E1002-E1007.
26. Morino K, Petersen KF & Shulman GI. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006 55 S9-S15.
27. Ibanez J, Izquierdo M, Arguelles I, Forga L, Larrion JL, Garcia-Unciti M, Idoate F & Gorostiaga EM. Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes Care 2005 28 662-667.
28. Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH & Staepoole PW. Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care 2003 26 557-562.
29. Ishii T, Yamakita. T, Sato T, Tanaka S & Fujii S. Resistance training improves insulin sensitivity in NIDDM subjects without altering maximal oxygen uptake. Diabetes Care 1998 21 1353-1355.
30. Dela F. Ploug T, Handberg A, Petersen LN, Larsen JJ, Mikines KJ & Galbo H. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes 1994 43 862-865.
31. Perseghin G, Price TB, Petersen KF, Roden M, Cline GW Gerow K, Rothman DL & Shulman GI. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. New England Journal of Medicine 1996 335 1357-1362.
32. Rogers MA, Yamamoto C, Hagberg JM, Martin WH, III, Ehsani AA & Holloszy JO. Effect of 6 d of exercise training on responses to maximal and sub-maximal exercise in middle-aged men. Medicine and Science in Sports and Exercise 1988 20 260-264.
33. Van Loon LJ & Goodpaster BH. Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Pflügers Archiv 2006 451 606-616.
34. Koopman R, Manders RJ, Jonkers RA, Hul GB, Kuipers H & Van Loon LJ. Intramyocellular lipid and glycogen content are reduced following resistance exercise in untrained healthy males. European Journal of Applied Physiology 2006 96 525-534.
35. Chilibeck PD, Syrotuik DG & Bell GJ. The effect of strength training on estimates of mitochondrial density and distribution throughout muscle fibres. European Journal of Applied Physiology and Occupational Physiology 1999 80 604-609.
36. Colberg SR, Hagberg JM, Mccole SD, Zmuda JM, Thompson PD & Kelley DE. Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise. Journal of Applied Physiology 1996 8 2027-2033.
37. Allenberg K, Johansen K & Saltin B. Skeletal muscle adaptations to physical training in type II (non-insulin-dependent) diabetes mellitus. Acta Medica Scandinavica 1988 223 365-373.
38. Vestergaard H. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Danish Medical Bulletin 1999 46 13-34.
39. Aronson D, Sella R, Sheikh-Ahmad M, Kerner A, Avizohar O, Rispler S, Bartha P, Markiewlez W, Levy Y & Brook GJ. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. Journal of the American College of Cardiology 2004 44 2003-2007.
40. Utzschneider KM & Kahn SE. Review: the role of insulin resistance in nonalcoholic fatty liver disease. Journal of Clinical Endocrinology and Metabolism 2006 91 4753-4761.
41. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA & Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 1821-1830.
42. Kriketos AD, Greenfield JR, Peake PW Furler SM, Denyer GS, Charlesworth JA & Campbell LV. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 2004 27 2033-2040.
43. Kahn SE, Zinman B, Haffner SM, O'neill MC, Kravitz BG, Yu D, Freed MI, Herman WIL Holman RR, Jones NP, Lachin JM & Viberti GC. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006 55 2357-2364.
44. Singleton JR, Smith AG, Russell JW & Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 2003 52 2867-2873.
45. Spijkerman AM, Gall MA, Tarnow L, Twisk JW, Lauritzen E, Lund-Andersen H, Emeis J, Parving HH & Stehouwer CD. Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in type 2 diabetes. Diabetic Medicine 2007 24 969-976.
46. Aas AM, Seljeflot I, Torjesen PA, Diep M Thorsby PM & Birkeland KI. Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes. Diabetologia 2006 49 872-880.
47. Oberbach A, Tonjes A, Kloting N, Fasshauer M, Kratzsch J, Busse MW, Paschke R, Stumvoll M & Bluher M. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. European Journal of Endocrinology 2006 154 577-585.
48. Perkins BA, Olaleye D, Zinman B & Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001 24 250-256.
49. Fairbarn MS, Blackie SP, Mcelvancy NG, Wiggs BR, Pare PD & Pardy RL. Prediction of heart rate and oxygen uptake during incremental and maximal exercise in healthy adults. Chest 1994 105 1365-1369.
50. Reynolds IM, Gordon TJ & Robergs RA. Prediction of one repetition maximum strength from multiple repetition maximum testing and anthropometry. Journal of Strength and Conditioning Research 2006 20 584-592.
51. Van Loon LJ, Koopman R, Stegen JH, Wagenmakers AJ, Keizer HA & Saris WH. IntramyoceBular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fasted state. Journal of Physiology 2003 553 611-625.
52. Mabuchi K & Sreter EA. Actomyosin ATPase. II. Fiber typing by histochemical ATPasc reaction. Muscle and Nerve 1980 3 233-239.
53. Schaart G, Hesselink RP, Keizer HA, Van Kranenburg G, Drost MR & Hesselink MK. A modified PAS stain combined with immunofluorescence for quantitative analyses of glycogen in muscle sections. Histochemistry and Cell Biology 2004 122 161-169.
54. Gosker HR, Van Mameren H, Van Dijk PJ, Engelen MP, Van Der Vusse GJ, Wouters EF & Schols AM. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. European Respiratory Journal 2002 19 617-625.
55. Meyer K, Samek L, Schwaibold M, Westbrook S, Hajric R, Lehmann M, Essfeld D & Roskamm H. Physical responses to different modes of interval exercise in patients with chronic heart failure - application to exercise training. European Heart Journal 1996 17 1040-1047.
56. Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Metz-Schimmerl S, Pacini G, Wagner O, Georg P, Prager R, Kostner K, Dunky A & Haber P. The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Archives of Physical Medicine and Rehabilitation 2005 86 1527-1533.
57. Castaneda C, Layne JE, Munoz-Orians L, Gordon PL, Walsmith J, Foldvari M, Roubenoff R, Tucker KL & Nelson ME. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care 2002 25 2335-2341.
58. Dunstan DW Puddey 1B, Beilin LJ, Burke V, Morton AR & Stanton KG. Effects of a short-term circuit weight training program on glycaemic control in NIDDM. Diabetes Research and Clinical Practice 1998 40 53-61.
59. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF & Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004 53 294-305.
60. Dunstan DW, Daly RM, Owen N, Jolley D, De Courten M, Shaw J & Zimmet P. High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care 2002 25 1729-1736.
61. Cauza E, Hanusch-Enserer U, Strasser B, Kostner K, Dunky A & Haber P. Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring system. European Journal of Clinical Investigation 2005 35 745-751.
62. Sigal RJ, Kenny GP, Boule NG, Wells GA, Prud'homme D, Fortier M, Reid RD, Tulloch H, Coyle D, Phillips P, Jennings A & Jaffey J. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Annals of Internal Medicine 2007 147 357-369.
63. Dunstan DW, Mori TA, Puddey IB, Bellin LJ, Burke V, Morton AR & Stanton KG. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study. Diabetes Care 1997 20 913-921.
64. Wagner H, Degerblad M, Thorell A, Nygren J, Stable A, Kuhl J, Brismar TB, Ohrvik J, Efendic S & Bavenholm PN. Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes. Diabetes Care 2006 29 1471-1477.
65. Braith RW & Stewart KJ. Resistance exercise training: its role in the prevention of cardiovascular disease. Circulation 2006 113 2642-2650.
66. Toledo FG, Menshikova EV, Ritov VB, Azuma K, Radikova Z, Delany J & Kelley DE. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship to glucose control in type 2 diabetes mellitus. Diabetes 2007 56 2142-2147.
67. Wilmore JH, Green JS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner IS & Bouchard C. Relationship of changes in maximal and submaximal aerobic fitness to changes in cardiovascular disease and non-insulin-dependent diabetes mellitus risk factors with endurance training: the HERITAGE Family Study. Metabolism 2001 50 1255-1263.
68. Evans EM, Racette SB, Peterson LR, Villareal DT, Greiwe JS & Holloszy JO. Aerobic power and insulin action improve in response to endurance exercise training in healthy 77-87 yr olds. Journal of Applied Physiology 2005 98 40-45.
69. Schneider SH, Amorosa LF, Khachadurian AK & Ruderman NB. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia 1984 26 355-360.
70. Brooks N, Layne J, Gordon PL, Roubenoff R, Nelson ME & Castaneda-Sceppa C. Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. International Journal of Medical Sciences 2007 4 1-27.
71. Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK & Kjekshus JK. Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation. Clinical Cardiology 2004 27 199-203.
72. Marketou ME, Zacharis EA, Nikitovic D, Ganotakis ES, Parthenakis FI, Maliaraki N & Vardas PE. Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects. Angiology 2006 57 211-218.
73. Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays in Biochemistry 2006 42 105-117.
74. Dela F, Von Linstow ME, Mildnes KJ & Galbo H. Physical training may enhance β-cell function in type 2 diabetes. American Journal of Physiology. Endocrinology and Metabolism 2004 287 E1024-E1031.
75. UK Prospective Diabetes Study Group U. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 837-853.
76. Helge JW & Dela F. Effect of training on muscle triacylglycerol and structural lipids: a relation to insulin sensitivity? Diabetes 2003 52 1881-1887.
77. Gan SK, Kriketos AD, Ellis BA, Thompson CH, Kraegen EW & Chisholm DJ. Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care 2003 26 1706-1713.
78. Hurley BF, Nemeth PM, Martin WH, III, Hagberg JM, Dalsky GP & Holloszy JO. Muscle triglyceride utilization during exercise: effect of training. Journal of Applied Physiology 1986 60 562-567.
79. Bergman BC, Butterfield GE, Woffel EE, Casazza GA, Lopaschuk GD & Brooks GA. Evaluation of exercise and training on muscle lipid metabolism. American Journal of Physiology 1999 276 E106-E117.
80. Pruchnic R, Katsiaras A, He J, Winters C, Kelley DE & Goodpaster BH. Exercise training increases intramyocellular lipid and oxidative capacity in older adults. American Journal of Physiology. Endocrinology and Metabolism 2004 287 E857-E862.
81. Schrauwen-Hinderling VB, Schrauwen P, Hesselink MK, Van Engelshoven JM, Nicolay K, Saris WH, Kessels AG & Kooi ME. The increase in intramyocellular lipid content is a very early response to training. Journal of Clinical Endocrinology and Metabolism 2003 88 1610-1616.
82. Dunstan DW, Vulikh E, Owen N, Jolley D, Shaw J & Zimmet P. Community center-based resistance training for the maintenance of glycemic control in adults with type 2 diabetes. Diabetes Care 2006 29 2586-2591.